ライフサイエンスコーパス: nephron-sparing

1 tients with localized kidney cancer, such as nephron-sparing and minimally invasive techniques are si

2 of SRMs evolved from radical nephrectomy to nephron-sparing approaches.

3 h increasing experience, the indications for nephron sparing are increasing.

4 Nephron-sparing immunosuppression regimens are emerging

5 Nephron-sparing immunosuppression regimens are emerging

6 nimally invasive surgery (MIS) techniques in nephron-sparing management of T1b/T2 tumors.

7 D kidneys based on nephron mass matching and nephron sparing measures may provide optimal utilization

8 y is now performed as a standard therapeutic nephron-sparing option in patients who are poor candidat

9 ned patients who might benefit from elective nephron-sparing procedures without increasing the risk o

10 y reviewed our institutional experience with nephron sparing surgery (NSS) in patients with synchrono

11 pointing to the long-term health benefits of nephron sparing surgery over radical nephrectomy and its

12 l targeted molecular therapies (TMTs) before nephron-sparing surgery (NSS) in patients with renal cel

13 Nephron-sparing surgery (NSS) provides effective curativ

14 tional and oncologic outcomes of reoperative nephron-sparing surgery (NSS).

15 ney is an absolute indication for performing nephron-sparing surgery (NSS).

16 r time (from 69.0% to 42.5%), and the use of nephron-sparing surgery (partial nephrectomy and ablatio

17 Nephron-sparing surgery and laparoscopic nephrectomy con

18 such as gene expression profiling, PET, and nephron-sparing surgery are being incorporated into cont

19 The use of nephron-sparing surgery exceeds radical nephrectomy in p

20 Minimally invasive nephron-sparing surgery for renal tumors encompasses ext

21 ion and current status of minimally invasive nephron-sparing surgery for renal tumors.

22 the role of ultrasound screening followed by nephron-sparing surgery for some patients may be appropr

23 Laparoscopic nephron-sparing surgery has become more common for the t

24 o further spare renal parenchyma and perform nephron-sparing surgery in anatomically difficult scenar

25 Nephron-sparing surgery is also gaining wider acceptance

26 e unequivocal and the role of laparoscopy in nephron-sparing surgery is evolving.

27 Although nephron-sparing surgery is the gold standard treatment f

28 However, nephron-sparing surgery is the standard of care, when po

29 Minimally invasive nephron-sparing surgery modalities are associated with d

30 ors, there has been a definite trend towards nephron-sparing surgery over the past decade.

31 g surgery, multiple absolute indications for nephron-sparing surgery still exist, including the class

32 extending the benefits of minimally invasive nephron-sparing surgery to a wider audience of patients

33 tients who received surgical treatment, only nephron-sparing surgery was associated with a benefit in

34 ques such as gene expression profiling, PET, nephron-sparing surgery, and stem cell transplantation a

35 ques such as gene expression profiling, PET, nephron-sparing surgery, and stem cell transplantation a

36 areness has increased regarding the value of nephron-sparing surgery, even in the presence of a norma

37 Nephron-sparing surgery, initially developed for patient

38 the controversy surrounding the benefits of nephron-sparing surgery, multiple absolute indications f

39 s that can guide surgical decision-making in nephron-sparing surgery.

40 ion for patients desiring minimally invasive nephron-sparing surgery.

41 surgery or imaging surveillance and empiric nephron-sparing surgery.

42 de more opportunities for minimally invasive nephron-sparing surgery.

43 re less invasive alternatives for performing nephron-sparing surgery.

44 nd increasing applicability for laparoscopic nephron-sparing surgery.

45 resents an alternative method for performing nephron-sparing surgery.

46 uld be referred to centers with expertise in nephron sparing techniques, not transplant centers.

47 rom radical surgery to a current emphasis on nephron-sparing treatment.

48 tients with a small renal tumor is a form of nephron-sparing tumor excision or ablation, as this appr